InsidersTradesSigma
Follow the Senores Pharmaceuticals share price and the full management transaction log of the company, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €58.4bn. The latest transaction was reported on 25 May 2026 (Acquisition). Among the most active insiders: Swapnil Jatin Shah & Others. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Senores Pharmaceuticals is a publicly traded pharmaceutical company on the XBOM, specializing in the development of innovative drugs. It focuses on the research and commercialization of treatments for various diseases.